ArticleBritish journal of cancer2023

Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.

Yuka Asami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.